In Veritas Financials
| IVME Stock | USD 0.0001 0.00 0.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.0019 | 0.002 |
|
|
The financial analysis of In Veritas is a critical element in measuring its lifeblood. Investors should not minimize In Veritas' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
IVME | Select Account or Indicator |
Understanding current and past In Veritas Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of In Veritas' financial statements are interrelated, with each one affecting the others. For example, an increase in In Veritas' assets may result in an increase in income on the income statement.
Please note, the presentation of In Veritas' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, In Veritas' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of In Veritas' management manipulating its earnings.
In Veritas Stock Summary
In Veritas competes with Eldorado Gold, Griffon, Sphere Entertainment, Minerals Technologies, and Zedge. In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with near-patient testing applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. IN Veritas operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 7 people.Specialization | Financial Services, Financial Services |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| Business Address | The Green House, |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Phone | 44 14 6366 7347 |
| Currency | USD - US Dollar |
In Veritas Key Financial Ratios
| Price To Sales | 0.14 X | ||||
| Net Income | (3.67 M) | ||||
| Book Value Per Share | (0.13) X | ||||
| Market Capitalization | 8.61 K | ||||
| Total Asset | 111.95 K |
IVME Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining In Veritas's current stock value. Our valuation model uses many indicators to compare In Veritas value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across In Veritas competition to find correlations between indicators driving In Veritas's intrinsic value. More Info.In Veritas Medical is currently regarded as number one stock in return on asset category among its peers. It also is considered the number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value In Veritas by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.In Veritas Medical Systematic Risk
In Veritas' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. In Veritas volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on In Veritas Medical correlated with the market. If Beta is less than 0 In Veritas generally moves in the opposite direction as compared to the market. If In Veritas Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one In Veritas Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of In Veritas is generally in the same direction as the market. If Beta > 1 In Veritas moves generally in the same direction as, but more than the movement of the benchmark.
About In Veritas Financials
What exactly are In Veritas Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include In Veritas' income statement, its balance sheet, and the statement of cash flows. Potential In Veritas investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although In Veritas investors may use each financial statement separately, they are all related. The changes in In Veritas's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on In Veritas's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Today, most investors in In Veritas Stock are looking for potential investment opportunities by analyzing not only static indicators but also various In Veritas' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of In Veritas growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |